Titusville, NJ

     Bert Wickey
     Healthcare Policy & Advocacy Director
     [email protected]

Janssen Pharmaceuticals, Inc., a pharmaceutical company of Johnson & Johnson, has a longstanding legacy developing innovative therapies and supporting programs, especially in mental health.  In the 1950s the company's namesake, Dr. Paul Janssen, discovered and developed a novel schizophrenia treatment.  Since then, Janssen has pioneered the development of long-acting atypical injectable antipsychotics (LATs) for schizophrenia, offering patients long-acting symptom control.  The company remains unwavering in its commitment to helping improve the lives of patients and their families by focusing on access to care, and delivering new treatments.  Learn more at www.janssen.com and follow us on Twitter at @JanssenUS.